Publications by authors named "Claudia Mucciarini"

Claim this Profile
U
Understanding challenges and barriers to quality end-of-life care for patients with hematologic malignancies: a GIMEMA survey.
Leonardo Potenza, Fabio Efficace, Eleonora Borelli, Paola Fazi, Thomas Baldi, Claudia Mucciarini

Ann Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients.
Sebastiano Buti, Alessandro Olivari, Cristina Masini, Davide Bimbatti, Donata Sartori, Claudia Mucciarini

Ther Adv Urol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive Psychological Well-Being in Early Palliative Care: A Narrative Review of the Roles of Hope, Gratitude, and Death Acceptance.
Elena Bandieri, Eleonora Borelli, Sarah Bigi, Claudia Mucciarini, Fabio Gilioli

Curr Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.
Melissa Bersanelli, Elena Verzoni, Alessio Cortellini, Raffaele Giusti, Lorenzo Calvetti, Claudia Mucciarini

EClinicalMedicine· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stigma of Palliative Care among Patients with Advanced Cancer and Their Caregivers on Early Palliative Care.
Elena Bandieri, Eleonora Borelli, Fabio Gilioli, Sarah Bigi, Claudia Mucciarini

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions of Death Among Patients with Advanced Cancer Receiving Early Palliative Care and Their Caregivers: Results from a Mixed-Method Analysis.
Sarah Bigi, Vittorio Ganfi, Eleonora Borelli, Leonardo Potenza, Fabrizio Artioli, Claudia Mucciarini

Oncologist· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study.
Daniele Raggi, Patrizia Giannatempo, Laura Marandino, Francesco Pierantoni, Marco Maruzzo, Claudia Mucciarini

Clin Genitourin Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study.
Cristina Masini, Cinzia Iotti, Ugo De Giorgi, Roberto Salvatore Bellia, Sebastiano Buti, Claudia Mucciarini

Eur Urol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions of Hope Among Bereaved Caregivers of Cancer Patients Who Received Early Palliative Care: A Content and Lexicographic Analysis.
Sarah Bigi, Vittorio Ganfi, Eleonora Borelli, Leonardo Potenza, Fabrizio Artioli, Claudia Mucciarini

Oncologist· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21).
Alessia Mennitto, Emma Zattarin, Massimo Di Maio, Davide Bimbatti, Ugo De Giorgi, Claudia Mucciarini

Expert Rev Anticancer Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Cancer Patients' and Caregivers' Disease Perceptions While Receiving Early Palliative Care: A Qualitative and Quantitative Analysis.
Eleonora Borelli, Sarah Bigi, Leonardo Potenza, Sonia Eliardo, Fabrizio Artioli, Claudia Mucciarini

Oncologist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different semantic and affective meaning of the words associated to physical and social pain in cancer patients on early palliative/supportive care and in healthy, pain-free individuals.
Eleonora Borelli, Sarah Bigi, Leonardo Potenza, Fabrizio Artioli, Sonia Eliardo, Claudia Mucciarini

PLoS One· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak.
Melissa Bersanelli, Sebastiano Buti, Mimma Rizzo, Alessio Cortellini, Carlo Cattrini, Claudia Mucciarini

Ther Adv Urol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.
Umberto Basso, Antonella Facchinetti, Elisabetta Rossi, Marco Maruzzo, Vincenza Conteduca, Claudia Mucciarini

Oncologist· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
Orazio Caffo, Cinzia Ortega, Franco Nolè, Donatello Gasparro, Claudia Mucciarini

Eur J Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study).
Melissa Bersanelli, Sebastiano Buti, Alessio Cortellini, Marco Bandini, Giuseppe Luigi Banna, Claudia Mucciarini

Clin Med Insights Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b).
Marco Stellato, Daniele Santini, Elena Verzoni, Ugo De Giorgi, Francesco Pantano, Claudia Mucciarini

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study.
Sebastiano Buti, Melissa Bersanelli, Alessandro Viansone, Alessandro Leonetti, Cristina Masini, Claudia Mucciarini

Cancer Treat Res Commun· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7).
Daniele Santini, Marco Stellato, Ugo De Giorgi, Francesco Pantano, Delia De Lisi, Claudia Mucciarini

Am J Clin Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early versus delayed palliative/supportive care in advanced cancer: an observational study.
Elena Bandieri, Federico Banchelli, Fabrizio Artioli, Claudia Mucciarini, Giorgia Razzini

BMJ Support Palliat Care· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer.
Orazio Caffo, Donatello Gasparro, Giuseppe Di Lorenzo, Alberto Dalla Volta, Pamela Guglielmini, Claudia Mucciarini

Eur J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.
Melissa Bersanelli, Diana Giannarelli, Ugo De Giorgi, Sandro Pignata, Massimo Di Maio, Claudia Mucciarini

Ther Adv Med Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study.
Melissa Bersanelli, Sebastiano Buti, Giuseppe Luigi Banna, Ugo De Giorgi, Alessio Cortellini, Claudia Mucciarini

Immunotherapy· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Annamaria Ruzzo, Francesco Graziano, Francesca Galli, Fabio Galli, Eliana Rulli, Claudia Mucciarini

Sci Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Annamaria Ruzzo, Francesco Graziano, Francesca Galli, Fabio Galli, Eliana Rulli, Claudia Mucciarini

Sci Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis